- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03822026
Hyperventilation in Patients With Traumatic Brain Injury
Effects of Moderate Hyperventilation on Cerebral Hemodynamics, Oxygenation and Metabolism in Patients With Severe Traumatic Brain Injury
Elevated intracranial pressure is a dangerous and potentially fatal complication after traumatic brain injury. Hyperventilation is a medical intervention to reduce elevated intracranial pressure by inducing cerebral vasoconstriction, which might be associated to cerebral ischemia and hypoxia.
The main hypothesis is that a moderate degree of hyperventilation is sufficient to reduce the intracranial pressure without inducing cerebral ischemia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In patients with severe traumatic brain injury (TBI), and with intracranial pressure-monitoring, brain tissue oxygen tension and/or microdialysis probes hyperventilation-tests are performed in the acute phase after trauma. Data are collected and TCCD measurements are performed at baseline, at the beginning of moderate hyperventilation, after prolonged moderate hyperventilation (for 50 minutes) and after return to baseline.
The present study aims to quantify potential adverse effects of moderate short-term hyperventilation during the acute phase of the severe TBI on cerebral hemodynamics, oxygenation, and metabolism.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8006
- University Hospital Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- nonpenetrating traumatic brain injury
- Glasgow coma scale <9 at presentation
- Intracranial pressure monitoring
- brain tissue oxygen tension monitoring and/or microdialysis monitoring
- invasive mechanical ventilation with FIO2 <60% and PEEP <15 mbar
Exclusion Criteria:
- decompressive craniectomy
- pregnancy
- pre-existing neurological disease
- previous traumatic brain injury
- acute cardiovascular disease
- severe respiratory failure
- acute on chronic liver disease
- sepsis
- failure to obtain satisfactory bilateral TCCD signals
- persisting hypovolemia or hemodynamic instability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: patients with severe TBI
Patients with severe TBI enrolled in the study undergo an hyperventilation test, in which the alveolar ventilation is increased by a stepwise increase in tidal volumes and respiratory rate until a reduction of etCO2 of 0.7 kPa is achieved.
|
Increase of the alveolar ventilation by a stepwise increase in tidal volumes and respiratory rate until a reduction of end-tidal CO2 of 0.7 kPa is achieved
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intracranial pressure
Time Frame: 10, 20, 50, 60 minutes after begin of the hyperventilation test
|
Change of intracranial pressure during moderate hyperventilation
|
10, 20, 50, 60 minutes after begin of the hyperventilation test
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cerebral flow velocity in the middle cerebral artery
Time Frame: 20, 50, 60 minutes after begin of the hyperventilation test
|
Change of cerebral flow velocity during moderate hyperventilation
|
20, 50, 60 minutes after begin of the hyperventilation test
|
|
brain tissue oxygenation (PbrO2)
Time Frame: 10, 20, 50, 60 minutes after begin of the hyperventilation test
|
no changes
|
10, 20, 50, 60 minutes after begin of the hyperventilation test
|
|
cerebral Lactate/ Pyruvate ratio
Time Frame: 1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test
|
no changes
|
1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Peter Steiger, MD, University of Zurich
Publications and helpful links
General Publications
- Klinzing S, Stretti F, Pagnamenta A, Bechir M, Brandi G. Transcranial color-coded duplex sonography assessment of cerebrovascular reactivity to carbon dioxide: an interventional study. BMC Neurol. 2021 Aug 7;21(1):305. doi: 10.1186/s12883-021-02310-9.
- Brandi G, Stocchetti N, Pagnamenta A, Stretti F, Steiger P, Klinzing S. Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury. Crit Care. 2019 Feb 13;23(1):45. doi: 10.1186/s13054-018-2304-6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH 2012-0542 (1)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperventilation
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de BruxellesCompletedHypoxia | Hypercapnia | Hyperventilation SyndromeBelgium
-
Hacettepe UniversityCompleted
-
University Hospital, LilleCompleted
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de Bruxelles; Hopitaux Iris SudCompletedHyperventilation SyndromeBelgium
-
University Hospital, MontpellierAPARD Fonds de dotationTerminatedHyperventilation SyndromeFrance
-
Centre Hospitalier Régional d'OrléansCompletedHyperventilation SyndromeFrance
-
Brunel UniversityUniversity of Sao PauloUnknownBreathlessness | Hyperventilation Syndrome | Respiration Disorder | Breath ShortnessUnited Kingdom
-
Hasselt UniversityZOLRecruitingLow Back Pain, Recurrent | Hyperventilation SyndromeBelgium
-
University Hospital, RouenCompletedHyperventilation | Hypocapnia | Hyperventilation Syndrome | Alkalosis, RespiratoryFrance
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Persistent Asthma | Hyperventilation Syndrome | Difficult AsthmaFrance
Clinical Trials on Hyperventilation test
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de Bruxelles; Hopitaux Iris SudCompletedHyperventilation SyndromeBelgium
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompleted
-
Université Libre de BruxellesWithdrawnCognitive DysfunctionBelgium
-
Eysz, Inc.National Institute of Neurological Disorders and Stroke (NINDS)CompletedSeizures | Absence Epilepsy | Epilepsy in Children | Absence Seizures | Absence Epilepsy, Childhood | StaringUnited States
-
Jordan University of Science and TechnologyCompletedLaparoscopic Gastric Sleeve Surgery | ASA-I and II Risk Class Patients | Same SurgeonJordan
-
University of LeicesterCompletedHemorrhage | Blood Pressure | Stroke, Acute | Cerebral Brain HemorrhageUnited Kingdom
-
Tampere University HospitalCompletedCerebral Metabolism and PerfusionFinland
-
Sahlgrenska University Hospital, SwedenCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Persistent Asthma | Hyperventilation Syndrome | Difficult AsthmaFrance
-
University of New MexicoUniversity of California, San FranciscoTerminatedCerebral Cavernous MalformationUnited States